ArticleBreast cancer (Tokyo, Japan)2026
Abemaciclib plus endocrine therapy in chemotherapy-treated patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Kazutaka Narui et al.PubMed ↗Publisher ↗
No numbers read from the abstract.